DEF 14A

Company

Cogent Biosciences, Inc.

Filed

February 18, 2020

Period of Report

March 9, 2020

Accession Number

0001193125-20-040685

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →